Symbol="BOLT"
AssetType="Common Stock"
Name="Bolt Biotherapeutics"
Description="Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California."
CIK="1641281"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="52182000"
EBITDA="-83084000"
PERatio="None"
PEGRatio="None"
BookValue="4.17"
DividendPerShare="0"
DividendYield="0"
EPS="-2.12"
RevenuePerShareTTM="0.18"
ProfitMargin="0"
OperatingMarginTTM="-12.59"
ReturnOnAssetsTTM="-0.217"
ReturnOnEquityTTM="-0.422"
RevenueTTM="6742000"
GrossProfitTTM="1620000"
DilutedEPSTTM="-2.12"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.246"
AnalystTargetPrice="5.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.3"
PriceToBookRatio="0.27"
EVToRevenue="270.65"
EVToEBITDA="1.024"
Beta="0.825"
num_52WeekHigh="2.68"
num_52WeekLow="1.18"
num_50DayMovingAverage="1.577"
num_200DayMovingAverage="1.468"
SharesOutstanding="37813300"
DividendDate="None"
ExDividendDate="None"
symbol="BOLT"
open="1.39"
high="1.42"
low="1.33"
price="1.38"
volume="102069.00"
latest_trading_day="2023-07-21"
previous_close="1.40"
change="-0.02"
change_percent="-1.4286%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="47"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="53"
Volume_recent_avg="195586"
Change_recent_avg="0.01"
Delta_recent_avg="0.11"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="-0.25"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="53"
Aroon_momentum_negative="47"
image_negative_thumbnail_id_1="1136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0169.jpeg"
image_negative_thumbnail_id_2="1116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0149.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="656"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_positive_thumbnail_id_2="650"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
